-
Magic mushroom clinical trial treating depression
ABC News
Hausen: If these substances are proven to be effective in a clinical trial, a wider group of people may be offered these substances in the future.
-
Ayahuasca - The unparralleled greatest feeling or risky drug?
Sydney Morning Herald Article, 30 Apr 22. Carla Jaeger.
“Enlighten provides harm reduction sessions so patients have a clear understanding of what taking specific psychedelics – including ayahuasca – may look like, as well as assess the risks. Ayahuasca can be fatal if taken with particular medications.”
-
Psychedelic Start up to de-merge from Little Green Pharma
The Clinical Advisory Board comprises clinical psychologist and Senior Lecturer of Addiction at Edith Cowan University in Western Australia, Dr Stephen Bright; clinical psychologist and previous member of a psilocybin based clinical trial team at Imperial College London, Renee Harvey; and Chief Executive Officer and co-founder of Enlighten Mental Health, Eternity Hausen . 7 March 22
Ayahuasca - The Project
Our CEO Ms Eternity Hausen was featured on Channel 10’s the Sunday Project to discuss the risks of taking Ayahuasca.
1 May 22
Expert Panel - TGA announcement on rescheduling some psychedelic substances
During this event the panel explored the impact of changes made by the TGA decision to reschedule psychedelic substances, patient access, barriers and clinical trials. Our CEO, Eternity Hausen was also a part of this panel.
Listen up.
Listen to this podcast in which Eternity and Meg discuss harm reduction and decriminalisation of Psychedelics in Australia. The Podcast is hosted by Australian Psychedelic Society.
Released 17 Aug 22
